December 14, 2023
R&D Day 2023 Recap: Following the Science to Deliver on the Promise of RNAi Therapeutics
During our 2023 R&D Day, our leadership discussed several exciting innovations and provided a look ahead at the rapid growth and evoltuion of our pipeline.
Read More ›
December 6, 2023
Alnylam Named One of America's Most Responsible Companies by Newsweek for 2nd Year in a Ro ...
Alnylam has been named one of America's Most Responsible Companies by Newsweek for the 2nd year in a row.
Read More ›
December 4, 2023
Being a Steward of the Planet in an Energy-Intensive Industry
Learn about how Alnylam is sourcing renewable energy for energy-intensive operations including manufacturing
Read More ›
November 30, 2023
Alnylam Named #1 Largest Employer in MA for 3rd Year in a Row by The Boston Globe
Alnylam has been named the #1 Largest Employer in MA for the 3rd year in a row and a Top Place to Work for the 9th year in a row.
Read More ›
October 26, 2023
Alnylam Named a Top Science Employer by Science Magazine for the 5th Year in a Row
Alnylam has been named a Science Magazine Top Employer for the 5th year in a row.
Read More ›
September 6, 2023
First Consensus Recommendations for Holistic Care of People Living With Hereditary ATTR Am ...
The Amyloidosis Alliance has published the first-ever consensus recommendations for patient- and family-centred holistic care in ATTRv.
Read More ›
July 24, 2023
Alnylam Named a Best Workplace for Millennials for 2023 by Fortune and Great Place to Work
Alnylam is ranked #19 on Fortune and Great Place to Work's 2023 list of Best Workplaces for Millennials.
Read More ›
July 11, 2023
Alnylam Named a Best Workplace for Innovators for the 3rd Year in a Row by Fast Company
Alnylam has been named a Fast Company Best Workplace for Innovators for 2023, our 3rd year in a row.
Read More ›
June 23, 2023
Alnylam in the Community: CASPAR Partnership Highlight
Alnylam has partnered with community organization CASPAR (Cambridge And Somerville Programs for Addiction Recovery) for many years.
Read More ›
May 3, 2023
Building a Corporate Responsibility Program from the Ground Up: Key Learnings from Alnylam ...
If you are building your program or assessing your program, here are five key learnings which may be helpful to your organization
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site